双鹭药业(002038) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 was ¥272,756,275.72, representing a decrease of 5.57% compared to the same period last year[7]. - The net profit attributable to shareholders for Q3 2022 was ¥72,620,881.01, down 45.97% year-on-year[7]. - The net profit after deducting non-recurring gains and losses was ¥46,640,311.27, a decrease of 39.43% compared to the previous year[7]. - Total operating revenue for the period was RMB 826,971,410.27, a decrease of 9.5% compared to RMB 913,380,348.89 in the previous period[25]. - The net profit for the current period is 234,860,671.21, a decrease from 432,602,879.45 in the previous period, representing a decline of approximately 45.6%[29]. - The total profit for the current period is 249,916,261.73, compared to 478,412,041.11 in the previous period, indicating a decrease of about 47.8%[29]. - The operating profit for the current period is 249,910,918.77, down from 478,426,850.91, reflecting a decline of approximately 47.8%[29]. - The total comprehensive income for the current period is 236,420,702.77, compared to 428,017,810.54 in the previous period, indicating a decline of approximately 44.8%[31]. Cash Flow and Liquidity - The company reported a net cash flow from operating activities of ¥272,519,850.78, which decreased by 3.18% year-to-date[7]. - The cash flow from operating activities for the current period is 272,519,850.78, slightly down from 281,481,980.56 in the previous period, a decrease of about 3.4%[32]. - The cash flow from investment activities shows a net outflow of -88,191,009.75, compared to -89,267,194.02 in the previous period, indicating a slight improvement[34]. - The cash and cash equivalents increased to RMB 914,681,207.53 from RMB 827,837,220.81, showing improved liquidity[18]. - The cash and cash equivalents at the end of the period amount to 861,956,138.12, an increase from 709,926,217.46 at the end of the previous period, representing a growth of approximately 21.4%[34]. Assets and Liabilities - The total assets at the end of the reporting period were ¥5,886,266,765.85, an increase of 2.18% from the end of the previous year[7]. - Total assets reached RMB 5,886,266,765.85, up from RMB 5,760,463,945.50, indicating growth in the asset base[21]. - The total liabilities decreased slightly to RMB 426,128,684.50 from RMB 434,234,069.90, reflecting effective debt management[24]. - The equity attributable to shareholders increased to RMB 5,448,271,015.01 from RMB 5,311,497,706.49, demonstrating a positive trend in shareholder value[24]. Shareholder Information - The company had a total of 55,288 common shareholders at the end of the reporting period[14]. - Major shareholder Xu Mingbo held 22.63% of the shares, while Xinxing Bailu Investment Group Co., Ltd. held 16.63%[14]. - The number of shares held by the top ten shareholders totaled 5,550,100 shares, with significant holdings by major stakeholders[17]. Strategic Focus - The decline in revenue and net profit was attributed to changes in the fair value of other non-current financial assets and the impact of the pandemic[12]. - The company is focusing on market expansion and new product development as part of its strategic initiatives moving forward[20]. Investment and Expenses - Research and development expenses were RMB 97,002,245.20, a decrease of 19.6% from RMB 120,662,330.57 in the previous period, indicating a focus on cost efficiency[25]. - The company reported an investment income of RMB 51,030,248.52, down from RMB 81,838,595.58, suggesting a need for strategic review of investment activities[25]. - The investment income received in cash for the current period is 38,308,680.35, down from 64,046,797.80 in the previous period, a decrease of approximately 40.3%[34]. Earnings Per Share - The basic and diluted earnings per share for the current period are both 0.2316, down from 0.4243 in the previous period, reflecting a decrease of about 45.5%[31]. Foreign Exchange Impact - The company reported a foreign exchange loss of -4,585,068.91 in the previous period, while the current period shows a gain of 1,328,661.46, indicating a significant turnaround[30].